Who invested in Transcept Pharmaceuticals?
Transcept Pharmaceuticals's investors include New Enterprise Associates, InterWest Partners, New Leaf Venture Partners, Hercules Capital and Vivo Ventures, and 3 more on record.
United States · Series D startup
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2007, from 1 source
Transcept Pharmaceuticals's investors include New Enterprise Associates, InterWest Partners, New Leaf Venture Partners, Hercules Capital and Vivo Ventures, and 3 more on record.
Transcept Pharmaceuticals has raised $40M across 1 round since 2007.
Transcept Pharmaceuticals's most recent round was a Series D of $40M in Mar 2007.
Its most recent round, $40M in Mar 2007, is also its largest on record.
Transcept Pharmaceuticals's first round on record, in Mar 2007, was backed by New Enterprise Associates, InterWest Partners and New Leaf Venture Partners and 5 others.
Transcept Pharmaceuticals's latest named round is a Series D, in Mar 2007.
Transcept Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.